Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
81 studies found for:    "antibiotic resistance" | Open Studies
Show Display Options
Rank Status Study
21 Unknown  Simplified Selective Digestive Tract Decontamination for the Prevention of Intensive Care Unit Acquired Infections
Conditions: Bacteremia Associated With Intravascular Line;   Ventilator Associated Pneumonia;   Bacteremia
Intervention: Drug: Neomycin Colistin Nystatin Vancomycin
22 Recruiting Biofilms on Short-term Indwelling Ureteral Stents
Conditions: Ureteral Catheterization;   Biofilm;   Morbidity
Intervention: Other: Stent examination, urinary analysis, USSQ questionnaire
23 Not yet recruiting Building a Novel Antibiotic Stewardship Intervention for Nursing Homes
Condition: Antibiotics
Intervention: Behavioral: OASIS Collaborative
24 Recruiting A Relevance Study Between the Result of Clinical Drug Intervention and Next-generation Sequencing Technology Focused on Refractory Helicobacter Pylori Infection
Condition: Gastritis
Interventions: Device: The eradication times of the patients;   Device: The result of 13C-urea breath test after treatment
25 Not yet recruiting A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection
Conditions: Gastritis;   Gastric Ulcer
Interventions: Biological: Antibiotic selection based on the antibiotic susceptibility testing;   Genetic: PPI selection based on the CYP2C19 gene polymorphism;   Dietary Supplement: Probiotics usage based on the 16SrRNA sequencing
26 Recruiting Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: High-dose dual therapy (rabeprazole, amoxicillin);   Drug: Bismuth-containing quadruple therapy (rabeprazole, tripotassium dicitrate bismuthate, metronidazole, tetracycline)
27 Recruiting Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: High-dose dual therapy (rabeprazole, amoxicillin);   Drug: Bismuth-containing quadruple therapy (rabeprazole, tripotassium dicitrate bismuthate, metronidazole, tetracycline)
28 Recruiting Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced
Conditions: Urethritis;   Cervicitis;   Genital Mycoplasma Infection;   Chlamydia Trachomatis
Interventions: Drug: Azithromycin;   Drug: Doxycycline;   Drug: lymecycline
29 Recruiting The SCOUT Study: Short Course Therapy for Urinary Tract Infections in Children
Condition: Urinary Tract Infections
Interventions: Drug: Trimethoprim sulfamethoxazole, cefixime, or cephalexin;   Drug: Placebo
30 Unknown  Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple Therapy
Condition: Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Interventions: Drug: 10RAC+acetylcystein;   Drug: 10RAC+metronidazole
31 Unknown  Rabeprazole Based Sequential-Concommitant Hybrid Therapies for H. Pylori Infections
Condition: Helicobacter Pylori Infection
Interventions: Drug: RA5-RACM7;   Drug: RA3-RACM7;   Drug: RA7-RACM7
32 Unknown  Efficacy of 10-day Concomitant Regimen Versus High Dose Dual Therapy in Anti-Helicobacter Pylori Rescue Therapy
Condition: Helicobacter Pylori Infection
Interventions: Drug: high dose dual therapy;   Drug: concomitant therapy
33 Recruiting Clarithromycin Triple Therapy Plus Bismuth for Helicobacter Pylori First-line Treatment
Condition: Helicobacter Pylori Infection
Interventions: Drug: Esomeprazole;   Drug: Bismuth Potassium Citrate;   Drug: Clarithromycin;   Drug: Amoxicillin;   Drug: Metronidazole
34 Recruiting The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection
Condition: Helicobacter Infection
Interventions: Procedure: H. pylori culture and antimicrobial susceptibility testing;   Drug: 14 days empirical bismuth quadruple therapy (Proton pump inhibitor);   Drug: Metronidazole;   Drug: Tetracycline;   Drug: tripotassium dicitrate bismuthate;   Drug: 7 days tailored therapy Proton Pump Inhibitor;   Drug: Moxifloxacin;   Drug: Amoxicillin
35 Recruiting Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan Children
Conditions: Pneumonia;   Diarrhea;   Malaria;   Co-infection;   Death;   Malnutrition
Interventions: Drug: Azithromycin;   Drug: Placebo
36 Recruiting Effects of Antibiotic Prophylaxis on Recurrent UTI in Children
Conditions: Urinary Tract Infection;   Recurrent Urinary Tract Infection
Intervention: Drug: Antibiotic Prophylaxis
37 Not yet recruiting Can Probiotics be Used in the Prevention of Recurrent UTI in Paediatric Neurogenic Bladder
Condition: Urinary Tract Infection
Interventions: Other: Antibiotic;   Drug: Probiotic
38 Unknown  Microbiota and Related Metabolome in Omnivore, Vegetarian or Vegan Diets
Condition: Diet and Human Microbiota
Intervention: Other: Omnivore, vegetarian and vegan subjects.
39 Recruiting Conjunctival Flora Patterns After Serial Intravitreal Injections in Diabetic Patients
Conditions: Diabetic Retinopathy;   Diabetic Macular Edema
Intervention: Drug: povidone-iodine 4%
40 Recruiting Emergence of Gram-negative Resistance in Blood Culture Isolates of Solid-organ Transplant Recipients
Condition: Gram Negative Infection
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years